CTAG1B, cancer/testis antigen 1B, 1485

N. diseases: 166; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE Despite the advanced stage of the disease, the vaccination induced systemic NY-ESO-1 specific CD8 T cells releasing IFN-γ in response to activation with the NY-ESO-1 peptide and an HLA-A2 positive neuroblastoma cell line. 30326856 2018
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 AlteredExpression disease BEFREE Finally, we demonstrate that the arginase activity of neuroblastoma impairs NY-ESO-1-specific T-cell receptor and GD2-specific chimeric antigen receptor-engineered T-cell proliferation and cytotoxicity. 26054597 2015
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE MAGE-A1, MAGE-A3, and NY-ESO-1-specific CTL were cultured from volunteer donors by stimulating peripheral blood mononuclear cells with dendritic cells pulsed with overlapping peptide mixes derived from full-length proteins, and these CTL preferentially lysed HLA partially matched, DAC-treated neuroblastoma and glioblastoma cell lines. 21626030 2011
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE NY-ESO-1-specific CD4(+) and CD8(+) T cells were also able to recognize NY-ESO-1 expressing neuroblastoma cells. 14583496 2003
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.050 Biomarker disease BEFREE Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. 10472332 1999